Deborah Fowell, professor and chair of the Department of Microbiology and Immunology in the College of Veterinary Medicine, has received a five-year, $2.32 million MERIT award from the NIH to study the factors that help guide immune cells.
A new gene-editing tool created by Weill Cornell Medicine investigators will enable cancer researchers to study the impact of specific genetic changes in preclinical models.
Pregnant women who had a previous COVID-19 infection and received full vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies, according to a new study.
In a rural part of upstate New York, students with access to school-based health centers received more medical care and missed less school, Cornell researchers found.
Many medical studies record a patient’s race using only the broad categories from the U.S. Census, which may conceal racial health disparities, a new Cornell-led study reports.
A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.
Only one in five Medicaid enrollees diagnosed with hepatitis C virus started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University’s Ithaca campus.
An interdisciplinary Cornell team has identified a new mechanism regulating tumor growth in the skeleton, the primary site of breast cancer metastasis: mineralization of the bone matrix.
